SCHMIDT DONAL RAY JR. (President and CEO) sold 7.7% of their position (4.27M shares) of RAPID THERAPEUTIC SCIENCE LABORATORIES, INC. on the open market
Open‑market sale worth $1.15M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 2/4/2021ACC: 0001393905-21-000039
→
DirectorOfficer10% Owner· President and CEO
Since Dec 2020
-89.67M
Net shares
Net seller
$1.15M
Total sold
3
Open market trades
0B · 3S
5
Total transactions
54.60M acquired · 144.27M disposed
Non-Derivative Transactions5
Common Stock
Indirect
Shares
−140M
Price / share
—
Trade value
—
% of position
New position
12/2/2020
140M→0.00
Common Stock
Indirect
Shares
+54.60M
Price / share
—
Trade value
—
% of position
New position
12/2/2020
0.00→54.60M
Common Stock
Indirect
Shares
−600K
Price / share
$0.25
Trade value
$150K
% of position
1.2%
12/22/2020
50.93M→50.33M
Common Stock
Indirect
Shares
−1.67M
Price / share
$0.30
Trade value
$500K
% of position
3.1%
12/28/2020
54.60M→52.93M
Common Stock
Indirect
Shares
−2M
Price / share
$0.25
Trade value
$500K
% of position
3.8%
12/28/2020
52.93M→50.93M
Total
Net shares
−89.67M
Net value
-$1.15M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 12/2/2020 | J · J | −140M | — | — | New position | 140M | 0.00 |
| Common Stock Indirect | 12/2/2020 | J · J | +54.60M | — | — | New position | 0.00 | 54.60M |
| Common Stock Indirect | 12/22/2020 | S · Sale | −600K | $0.25 | $150K | 1.2% | 50.93M | 50.33M |
| Common Stock Indirect | 12/28/2020 | S · Sale | −1.67M | $0.30 | $500K | 3.1% | 54.60M | 52.93M |
| Common Stock Indirect | 12/28/2020 | S · Sale | −2M | $0.25 | $500K | 3.8% | 52.93M | 50.93M |
| Total | −89.67M | -$1.15M | ||||||
Derivative Transactions0
No derivative transactions reported